These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. A new potentially antianginal benzofuran with an amiodarone-like pharmacological profile. Charlier R; Bauthier J Arzneimittelforschung; 1973 Sep; 23(9):1305-11. PubMed ID: 4801226 [No Abstract] [Full Text] [Related]
23. The blocking effects of propranolol, practolol and ICI-66082 on the peripheral vascular responses to isoprenaline. Hainsworth R; Karim F; Stoker JB; Harry JD Br J Pharmacol; 1973 Jun; 48(2):342P-343P. PubMed ID: 4147430 [No Abstract] [Full Text] [Related]
24. [Specific differences between the adrenergic beta receptors of the heart and coronary vessels]. Bayer BL; Mentz P; Förster W Arch Int Pharmacodyn Ther; 1972 Dec; 200(2):341-7. PubMed ID: 4405155 [No Abstract] [Full Text] [Related]
25. Antagonism of cardiac arrhythmias by beta-adrenoreceptor blocking agents. Laddu AR; Kumakura S; Somani P Arch Int Pharmacodyn Ther; 1972 Nov; 200(1):168-81. PubMed ID: 4404932 [No Abstract] [Full Text] [Related]
26. Beta-adrenergic blocking agents. 19. 1-Phenyl-2-[[(substituted-amido)alkyl]amino]ethanols. Large MS; Smith LH J Med Chem; 1980 Feb; 23(2):112-7. PubMed ID: 6102152 [TBL] [Abstract][Full Text] [Related]
27. [The beta-adrenergic blocking and antiarrhythmic activities of metabolites of befunolol hydrochloride (author's transl)]. Masumoto S; Inoue H; Maruyama Y Nihon Yakurigaku Zasshi; 1979 Jul; 75(5):517-25. PubMed ID: 44259 [No Abstract] [Full Text] [Related]
28. Beta-receptor blocking and cardiodepressant actions of 2-nitrilophenoxypropanolamines. Mylecharane EJ; Raper C Eur J Pharmacol; 1971 Sep; 16(1):14-20. PubMed ID: 4400509 [No Abstract] [Full Text] [Related]
29. Pharmacology of nadolol (SQ 11725), a beta-adrenergic antagonist lacking direct myocardial depression. Lee RJ; Evans DB; Baky SH; Laffan RJ Eur J Pharmacol; 1975; 33(2):371-82. PubMed ID: 241655 [TBL] [Abstract][Full Text] [Related]
30. Studies on the myocardial depressant effect of KL 255: a beta adrenergic receptor antagonist. Pendleton RG; Petta JM; Hahn RA Arch Int Pharmacodyn Ther; 1970 Sep; 187(1):75-87. PubMed ID: 4394700 [No Abstract] [Full Text] [Related]
31. Studies on agents with vasodilator and beta-blocking activities. I. Seki T; Takezaki T; Ohuchi R; Ohuyabu H; Ishimori T; Yasuda K Chem Pharm Bull (Tokyo); 1994 Aug; 42(8):1609-16. PubMed ID: 7954913 [TBL] [Abstract][Full Text] [Related]
32. Elevation of ventricular fibrillatory threshold by beta-adrenergic blocking agents. Baum T; Peters JR; Eckfeld DK; Varner LL; Dinish J; Metz N; Shropshire AT Arch Int Pharmacodyn Ther; 1972 Dec; 200(2):292-300. PubMed ID: 4405153 [No Abstract] [Full Text] [Related]